Sort   by:  
 Page size 
UnknownThe Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
Not available
S-EPMC6292383 | biostudies-literature
UnknownLongitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Not available
S-EPMC7545591 | biostudies-literature
UnknownStructural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2.
Not available
S-EPMC1189343 | biostudies-literature
UnknownLocation of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
Not available
S-EPMC2665081 | biostudies-literature
UnknownLevetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats.
Not available
S-EPMC2848232 | biostudies-literature
UnknownClinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Not available
S-EPMC6956652 | biostudies-literature
UnknownKinetic modelling of sterol transport between plasma membrane and endo-lysosomes based on quantitative fluorescence and X-ray imaging data.
Not available
S-EPMC10644255 | biostudies-literature
UnknownDiagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Not available
S-EPMC4575273 | biostudies-literature
UnknownInnate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer.
Not available
S-EPMC9791214 | biostudies-literature
UnknownMutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
Not available
S-EPMC2804362 | biostudies-literature
Sort   by:  
 Page size